NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117965	Articles
99397	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/21/2025 at 22:20, 6 months 15 days ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
PRESS RELEASE

published on 05/21/2025 at 22:15, 6 months 15 days ago

Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
Nanobiotix annonce ses progrès opérationnels et sa trésorerie pour le premier trimestre 2025, avec un renforcement financier et des avancées dans le traitement du cancer du poumon

Trésorerie Études Cliniques NANOBIOTIX Cancer Du Poumon JNJ-1900
PRESS RELEASE

published on 05/21/2025 at 22:15, 6 months 15 days ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Nanobiotix provides operational and financial update for Q1 2025, including CONVERGE study dosing, financial strengthening, and €39.8M cash reserves as of March 31, 2025

Operational Update Financial Update Cash Reserves NANOBIOTIX CONVERGE Study
BRIEF

published on 04/14/2025 at 22:20, 7 months 21 days ago

Nanobiotix : Mise à jour mensuelle des droits de vote et actions

Droits De Vote Euronext Capital Social Nasdaq NANOBIOTIX
BRIEF

published on 04/14/2025 at 22:20, 7 months 21 days ago

Nanobiotix: Monthly update of voting rights and shares

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 04/14/2025 at 22:15, 7 months 21 days ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Communiqué de presse mensuel sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations boursières et financières détaillées. Présentation de l'entreprise et de ses activités

Innovation Euronext Paris Droits De Vote Biotechnologie NANOBIOTIX
PRESS RELEASE

published on 04/14/2025 at 22:15, 7 months 21 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital updates. The late-stage biotech company aims to improve treatment outcomes through innovative therapies

Voting Rights Shares Capital Biotechnology Company NANOBIOTIX Treatment Outcomes
BRIEF

published on 03/27/2025 at 21:20, 8 months 9 days ago

Nanobiotix dévoile les données de phase 1 sur le traitement du cancer du poumon non à petites cellules

Étude De Phase 1 NBTXR3 CPNPC Radioenhancer Données Des Essais Cliniques
BRIEF

published on 03/27/2025 at 21:20, 8 months 9 days ago

Nanobiotix Unveils Phase 1 Data on NSCLC Therapy

NSCLC NBTXR3 Phase 1 Study Radioenhancer Clinical Trial Data
PRESS RELEASE

published on 03/27/2025 at 21:15, 8 months 9 days ago

Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Nanobiotix announces first data from the completed dose escalation part of a Phase 1 study evaluating NBTXR3 (JNJ-1900) as a 2L+ therapy for patients with locally advanced NSCLC. The study shows favorable safety and injection feasibility, with promising survival data

NSCLC NANOBIOTIX NBTXR3 Phase 1 Study Dose Escalation

Accesswire

Published on 12/06/2025 at 00:00, 20 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 50 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 30 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 35 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 50 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 2 hours 4 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 8 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 22 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 54 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 6 hours 5 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 2 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE